Replies to post #30952 on Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Take the more recently filed Ranolazine, or Ranexa for example. Currently, there are only about 6 manufacturers, and those are pretty expensive pills too. So current market looks favorable to get this through approval and will likely get a partnership right away.

??? There are no other manufacturers for Ranexa - it's still patent protected till May 2019.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135031918

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135031964